Join our community

About the community

“Be our biotech future”

The goal of this biotechnology community is to build unity among people working or engaged in the biotechnology industry on an international level. The community is a place for people to come together and share thoughts, ideas and knowledge. Members of the community enjoy a wide variety of relevant information, which includes the latest newsinterviewsblogs, and vacancies from the biotechnology industry. 

DNA-based material with tunable properties

17 June 2021

While DNA is often idealised as the “molecule of life,” it is also a highly sophisticated polymer that can be used for next-generation materials. Beyond the fact that it can store information, further fascinating aspects of DNA are its geometric and topological properties, such as knotting and super-coiling. Indeed, very much like a twisted telephone cord, DNA is often found coiled up inside bacteria and other cells and even knotted in viruses. Now, a collaboration of scientists from the Universities of Edinburgh, San Diego and Vienna have started to harness these properties to craft “topologically tunable” DNA-based complex fluids and soft materials with potential applications in drug delivery and tissue regeneration as published in Science Advances.

Read more

Pain-killing molecule developed with enhanced pharmaco properties

15 June 2021

Researchers from the immuno-pharmacology and interactomics group at the department of infection and immunity of the Luxembourg Institute of Health (LIH), in collaboration with the Center for Drug Discovery at RTI International (RTI), a nonprofit research institute, report that they have demonstrated that conolidine, a natural painkiller derived from the pinwheel flower and traditionally used in Chinese medicine, interacts with the newly identified opioid receptor ACKR3/CXCR7 that regulates opioid peptides naturally produced in the brain. The investigators also developed a synthetic analog of conolidine, RTI-5152-12, which displays greater activity on the receptor.

Read more
novel drug approvals 2020
billion dollar spent on R&D globally
active clinical trials in Europe


All events

Poll Question

Use of biomarkers in deciding how to treat a patient?
See following article >>


Sign up

    Fill in your contact details to sign up for our newsletter.